Research Article
In Silico Study of Coumarins: Wedelolactone as a Potential Inhibitor of the Spike Protein of the SARS-CoV-2 Variants
Table 3
Evaluation of Lipinski’s RO5 and drug score for the top 10 best-docked coumarins and reference ligands.
| S. No. | Compounds | Molecular weight (≤500) | Hydrogen bond donor (≤5) | Hydrogen bond acceptor (≤10) | CLogP (≤5) | Lipinski drug-likeness | Drug score |
| 1 | Inophyllum C | 402.44 | 0 | 5 | 4.34 | Yes | 0.09 | 2 | (+)-Rutamarin | 356.41 | 0 | 5 | 4.02 | Yes | 0.15 | 3 | Cordatolide A | 342.39 | 1 | 5 | 3.17 | Yes | 0.14 | 4 | Soulattrolide | 404.46 | 1 | 5 | 4.11 | Yes | 0.10 | 5 | Wedelolactone | 314.25 | 3 | 7 | 2.09 | Yes | 0.30 | 6 | Inophyllum A | 404.46 | 1 | 5 | 4.11 | Yes | 0.10 | 7 | Inophyllum E | 402.44 | 0 | 5 | 4.34 | Yes | 0.09 | 8 | (+)-Calanolide C | 370.44 | 1 | 5 | 3.79 | Yes | 0.12 | 9 | Inophyllum B | 404.46 | 1 | 5 | 4.09 | Yes | 0.11 | 10 | Inophyllum D | 404.46 | 1 | 5 | 4.13 | Yes | 0.10 | 11 | Molnupiravir | 329.31 | 4 | 8 | −1.16 | Yes | 0.18 | 12 | Ceftazidime | 546.58 | 3 | 11 | −1.39 | No | 0.66 |
|
|
Note. Parenthetical figures indicate the threshold levels for Lipinski’s RO5.
|